Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stop The Bleeding: Sanofi-Aventis Looks To Sell A Generic Plavix In Europe

This article was originally published in The Pink Sheet Daily

Executive Summary

If a bioequivalent version of the clot buster launches in France, Sanofi is preparing to roll out its own generic version of clopidogrel.
Advertisement

Related Content

AstraZeneca's Brilique Approved In The EU
AstraZeneca's Brilique Approved In The EU
Health Reform Magnifies Payers' Invisible Place At The Licensing Table
Health Reform Magnifies Payers' Invisible Place At The Licensing Table
Effient Labeling Could Give Edge Against Plavix Through Pharmacogenetics
Plavix Patent Upheld By Court, Blocking Generic Clopidogrel
Plavix Patent Upheld By Court, Blocking Generic Clopidogrel

Topics

Advertisement
UsernamePublicRestriction

Register

PS068702

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel